LGD-4033 SARMS has similar effects to anabolics with size and strength with minimal side effects. It works well alone or stacked with other SARMs. It has a half-life of 24 to 36 hours.
LGD-4033 SARMS (VK5211, Ligandrol) is an investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis, LGD-4033 binds to the androgen receptor of muscle and bone selectively, exhibiting similar effects as testosterone*, with only partial agonist activity on the prostate. It was developed as a way to treat diseases or conditions associated with muscle and bone deterioration. The advantage a SARM like LGD has over testosterone is the difference in activity it has on the body outside of muscle and bone. Anecdotal evidence shows that human use of LGD-4033 will result in reduction of natural testosterone production. This is because the body thinks the compound is testosterone and therefore produces less.
*All prices in Canadian dollars. The information presented here is intended for educational / informational purposes only